Literature DB >> 20824752

Quality of life and health status after percutaneous coronary intervention in stable angina patients: results from the real-world practice.

Alexandre S de Quadros1, Tatiane C Lima, Ana Paula da Rosa Rodrigues, Thais B Modkovski, Dulce I Welter, Rogério Sarmento-Leite, Carlos A M Gottschall.   

Abstract

BACKGROUND: Percutaneous coronary interventions (PCI) are associated with quality of life (QoL) and health status improvements in stable angina patients. There are few studies assessing the magnitude of this effect and its predictors in contemporary daily practice.
METHODS: Prospective cohort study with stable angina patients submitted to PCI in a tertiary interventional cardiology center. The clinical characteristics and the Seattle Angina Questionnaire (SAQ) were assessed before PCI, and patients were followed-up for 1 year. Mixed linear regression and ANOVA were used to compare SAQ indices, and multivariate analysis to identify predictors of QoL improvement.
RESULTS: Between September 2006 and May 2007, 110 patients were included. The mean age of the study population was 62.8 ± 8.7 years, and 62% of the patients were of the male gender. Diabetes mellitus was present in 29%, arterial hypertension in 82%, previous myocardial infarction in 32%, and previous PCI in 29%. Before PCI, only 5% of the patients were free of angina, and this rate improved to 68% in the one-year followup (P < 0.001). There was improvement in all SAQ scales in the one-year followup, which was already shown in the 6-month assessment (P < 0.0001). Quality of life before the procedure was the main predictor of QoL improvement by multivariate analysis (P < 0.001).
CONCLUSIONS: Patients with stable angina submitted to PCI in the real-world practice present significant improvement in one-year health status, as assessed by the SAQ. Quality of life before the procedure is the main determinant of improvement in QoL.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20824752     DOI: 10.1002/ccd.22746

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62.

Authors:  Tang-Jun Ai; Jian-Yong Sun; Lin-Juan Du; Chaoji Shi; Chao Li; Xue-Nan Sun; Yan Liu; Lihui Li; Zhixiong Xia; Lijun Jia; Jianmiao Liu; Sheng-Zhong Duan
Journal:  Cell Death Differ       Date:  2017-10-13       Impact factor: 15.828

2.  Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease.

Authors:  Michael Wester; Franziska Koll; Mark Luedde; Christoph Langer; Markus Resch; Andreas Luchner; Karolina Müller; Florian Zeman; Michael Koller; Lars S Maier; Samuel Sossalla
Journal:  Clin Res Cardiol       Date:  2022-09-13       Impact factor: 6.138

3.  Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial.

Authors:  Michelle C Williams; Amanda Hunter; Anoop Shah; Valentina Assi; Stephanie Lewis; Kenneth Mangion; Colin Berry; Nicholas A Boon; Elizabeth Clark; Marcus Flather; John Forbes; Scott McLean; Giles Roditi; Edwin Jr van Beek; Adam D Timmis; David E Newby
Journal:  Heart       Date:  2017-02-28       Impact factor: 5.994

4.  Predictors of subjective health status 10 years post-PCI.

Authors:  Jan C van den Berge; Karolijn Dulfer; Elisabeth M W J Utens; Eline M J Hartman; Joost Daemen; Robert J van Geuns; Ron T van Domburg
Journal:  Int J Cardiol Heart Vasc       Date:  2016-03-16

5.  Anxiety and health-related quality of life after cardiac surgery.

Authors:  Yalcin Guzelhan; Murat Ugurlucan; Didem Melis Oztas; Metin Onur Beyaz; Orcun Unal; Nilufer Bektas; Cenk Conkbayir; Ufuk Alpagut; Nilgun Bozbuga
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-04-08

6.  Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature.

Authors:  Harindra C Wijeysundera; Sara Farshchi-Zarabi; William Witteman; Maria C Bennell
Journal:  Clinicoecon Outcomes Res       Date:  2014-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.